Showing results (181-190 of 291) with videos related to
Sort By:
Pageof 30
Journal of Medical Virology|April 17, 2013
Emergence of telaprevir-resistant variants detected by ultra-deep sequencing after triple therapy in patients infected with HCV genotype 1Norio Akuta, Fumitaka Suzuki, Yuya Seko, et al.Journal of Clinical Microbiology|November 8, 2013
Utility of detection of telaprevir-resistant variants for prediction of efficacy of treatment of hepatitis C virus genotype 1 infectionNorio Akuta, Fumitaka Suzuki, Taito Fukushima, et al.Virology Journal|December 25, 2015
Long-term effects of peginterferon alfa-2a therapy in Japanese patients with chronic hepatitis B virus infectionKeiichi Masaki, Fumitaka Suzuki, Tasuku Hara, et al.Hepatology Communications|February 7, 2018
Effects of a sodium-glucose cotransporter 2 inhibitor in nonalcoholic fatty liver disease complicated by diabetes mellitus: Preliminary prospective study based on serial liver biopsiesNorio Akuta, Chizuru Watanabe, Yusuke Kawamura, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 21, 2018
Efficacy and safety of elbasvir plus grazoprevir combination therapy in Japanese patients infected with hepatitis C virus genotype 1bYasue Takeuchi, Norio Akuta, Hitomi Sezaki, et al.Journal of Medical Virology|February 19, 2010
Amino acid substitutions in the hepatitis C virus core region of genotype 1b affect very early viral dynamics during treatment with telaprevir, peginterferon, and ribavirinNorio Akuta, Fumitaka Suzuki, Miharu Hirakawa, et al.Journal of Gastroenterology|October 1, 2021
Effectiveness of tenofovir alafenamide for chronic hepatitis B patients with a poor response to the previously used nucleos(t)ide analogsDaiki Yamashige, Tetsuya Hosaka, Fumitaka Suzuki, et al.Journal of Medical Virology|April 22, 2009
Amino acid substitutions in the hepatitis C virus core region of genotype 1b are the important predictor of severe insulin resistance in patients without cirrhosis and diabetes mellitusNorio Akuta, Fumitaka Suzuki, Miharu Hirakawa, et al.Journal of Medical Virology|November 22, 2005
Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral loadNorio Akuta, Fumitaka Suzuki, Hitomi Sezaki, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 29, 2014
Therapeutic effects of short- and intermediate-term tolvaptan administration for refractory ascites in patients with advanced liver cirrhosisShintaro Akiyama, Kenji Ikeda, Hitomi Sezaki, et al.Pageof 30